Inactive Instrument

Immunosyn Corp Share Price

Stocks

End-of-day quote Other OTC
- ^USD	-

30/-1/30	IMMUNOSYN CORP COM STK USD0.0001 : Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Files 10-Q	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Announces 2007 Results, Files 10KSB	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn	PR

Manager	Title	Age	Since
Stephen D. Ferrone CEO	Chief Executive Officer	75	15/10/2007
Douglas A. McClain DFI	Director of Finance/CFO	51	-

Director	Title	Age	Since
Stephen D. Ferrone BRD	Director/Board Member	75	09/07/2011
Douglas A. McClain CHM	Chairman	51	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MODERNA, INC.	+3.13%	+11.45%	+703.24%	+96.98%	8.12TCr
REGENERON PHARMACEUTICALS, INC.	-0.23%	-6.64%	+33.84%	-8.80%	7.49TCr
CSL LIMITED	+1.05%	+2.78%	-7.05%	-25.22%	6.09TCr
SAMSUNG BIOLOGICS CO.,LTD.	-1.07%	-0.43%	-10.19%	+32.27%	4.72TCr
UCB	-0.92%	-3.17%	-12.81%	+163.23%	4.47TCr
BIOGEN INC.	-0.71%	+0.76%	+63.93%	-11.65%	3.36TCr
INCYTE CORPORATION	-1.30%	-2.94%	+46.86%	+113.26%	2.5TCr
SWEDISH ORPHAN BIOVITRUM AB	+0.69%	-0.05%	+53.21%	+95.46%	1.52TCr
BRIDGEBIO PHARMA, INC.	-0.96%	-4.71%	+26.96%	+150.17%	1.29TCr
Average	-0.95%	-0.91%	+99.78%	+67.30%	4.4TCr
Weighted average by Cap.	-1.31%	+0.35%	+158.38%	+51.37%

Employees

Sector